FM

Finan Muhammed Faisal

Active Director Director DIN 11401723
DIN 11401723 First appointment Nov 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Finan Muhammed Faisal

Data last updated:

Finan Muhammed Faisal is a Director at Fismo Oistre Pharmaceuticals And Cosmetics Private Limited (since 2025). The company operates in Pharma.

DIN 11401723
Primary Designation Director
Industry Pharma
First Appointment 29 Nov 2025

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director29 Nov 20252025Active

Directorship timeline

Open interactive timeline →
Fismo Oistre Pharmaceuticals And Cosmetics Private Limited
Premium access

Shareholding and investment profile for Finan Muhammed Faisal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Finan Muhammed Faisal

Finan Muhammed Faisal currently holds 1 directorship: Fismo Oistre Pharmaceuticals And Cosmetics Private Limited (Director, since 29 Nov 2025).

Finan Muhammed Faisal was first appointed on 29 Nov 2025 as Director at Fismo Oistre Pharmaceuticals And Cosmetics Private Limited.

The current boards of Finan Muhammed Faisal's companies include Firil Muhammad Faisal (Fismo Oistre Pharmaceuticals And Cosmetics Private Limited), Komath Valluvasseri Muhammad (Fismo Oistre Pharmaceuticals And Cosmetics Private Limited), Mohammed Shahil (Fismo Oistre Pharmaceuticals And Cosmetics Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available